Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Malaria Journal|January 24, 2007
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistanceNeal Alexander, Colin Sutherland, Cally Roper, et al.
Molecular Ecology|April 21, 2009
Hitching a lift on the road to speciationCarole Smadja, Juan Galindo, Roger Butlin
Antimicrobial Agents and Chemotherapy|March 26, 2003
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern TanzaniaRichard J Pearce, Chris Drakeley, Daniel Chandramohan, et al.
Malaria Journal|March 15, 2017
Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78Irina T Jovel, Anders Björkman, Cally Roper, et al.
Malaria Journal|September 4, 2019
Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challengesDeus S Ishengoma, Queen Saidi, Carol H Sibley, et al.
Science (New York, N.Y.)|August 25, 2004
Intercontinental spread of pyrimethamine-resistant malariaCally Roper, Richard Pearce, Shalini Nair, et al.
Molecular Biology and Evolution|May 27, 2005
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparumRichard Pearce, Allen Malisa, S Patrick Kachur, et al.
Molecular Ecology|February 27, 2021
Using replicate hybrid zones to understand the genomic basis of adaptive divergenceAnja M Westram, Rui Faria, Kerstin Johannesson, et al.
Tropical Medicine & International Health : TM & IH|February 18, 2015
Association between recent internal travel and malaria in Ugandan highland and highland fringe areasCaroline A Lynch, Jane Bruce, Amit Bhasin, et al.
Malaria Journal|May 5, 2007
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'ZérékoréMaryline Bonnet, Cally Roper, Martine Félix, et al.
Pageof 11